Home
About
Overview
Sharing Data
ORCID
Help
History (51)
Preoperative Care
Equilin
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
See All 51 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology. 2008 Oct 28; 71(18):1390-5.
View in:
PubMed
subject areas
Adult
Analysis of Variance
Chi-Square Distribution
Cholesterol
Dose-Response Relationship, Drug
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
Heptanoic Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunologic Factors
Interferon-beta
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
Neurologic Examination
Pyrroles
Survival Analysis
authors with profiles
Anthony Reder